Format
Items per page
Sort by

Send to:

Choose Destination

Results: 9

Related Articles by Review for PubMed (Select 21615243)

1.

First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience.

Olsen IH, Langer SW, Jepsen I, Assens M, Federspiel B, Hasselby JP, Hansen CP, Kjaer A, Knigge U.

Acta Oncol. 2012 Jan;51(1):97-100. doi: 10.3109/0284186X.2011.582881. Epub 2011 May 26.

PMID:
21615243
2.

The treatment of undifferentiated neuroendocrine tumors.

Mitry E, Rougier P.

Crit Rev Oncol Hematol. 2001 Jan;37(1):47-51. Review.

PMID:
11164718
3.

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.

PMID:
12042984
4.

Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.

Sonett JR, Suntharalingam M, Edelman MJ, Patel AB, Gamliel Z, Doyle A, Hausner P, Krasna M.

Ann Thorac Surg. 2004 Oct;78(4):1200-5; discussion 1206. Review.

PMID:
15464470
5.

A systematic overview of chemotherapy effects in ovarian cancer.

Högberg T, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):340-60. Review.

PMID:
11441940
6.

Treatment of poorly differentiated neuroendocrine carcinoma of the pancreas.

Gupta A, Duque M, Saif MW.

JOP. 2013 Jul 10;14(4):381-3. doi: 10.6092/1590-8577/1661. Review.

7.

Chemotherapy in gastroenteropancreatic (GEP) neuroendocrine carcinomas (NEC): a critical view.

Fazio N, Spada F, Giovannini M.

Cancer Treat Rev. 2013 May;39(3):270-4. doi: 10.1016/j.ctrv.2012.06.009. Epub 2012 Jul 20. Review.

PMID:
22819619
8.

Current concepts in the diagnosis and management of poorly differentiated gastrointestinal neuroendocrine carcinomas.

Koumarianou A, Chatzellis E, Boutzios G, Tsavaris N, Kaltsas G.

Endokrynol Pol. 2013;64(1):60-72. Review.

PMID:
23450449
9.

The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas.

Strosberg JR, Coppola D, Klimstra DS, Phan AT, Kulke MH, Wiseman GA, Kvols LK; North American Neuroendocrine Tumor Society (NANETS).

Pancreas. 2010 Aug;39(6):799-800. doi: 10.1097/MPA.0b013e3181ebb56f.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk